- Home
- OSW vs NVCR Comparison
OSW vs NVCR Comparison
Compare OSW & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OSW | NVCR |
|---|---|---|
| Founded | 2017 | 2000 |
| Country | Bahamas | Switzerland |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.0B |
| IPO Year | 2019 | 2015 |
Fundamental Metrics
Financial Performance| Metric | OSW | NVCR |
|---|---|---|
| Price | $23.78 | $14.71 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 7 |
| Target Price | ★ $31.20 | $26.86 |
| AVG Volume (30 Days) | 612.5K | ★ 1.4M |
| Earning Date | 10-28-2026 | 10-29-2026 |
| Dividend Yield | ★ 0.82% | N/A |
| EPS Growth | N/A | ★ 21.79 |
| EPS | ★ 0.44 | N/A |
| Revenue | ★ $961,001,000.00 | $655,353,000.00 |
| Revenue This Year | $7.61 | $10.80 |
| Revenue Next Year | $8.69 | $10.83 |
| P/E Ratio | $55.16 | ★ N/A |
| Revenue Growth | 7.37 | ★ 8.28 |
| 52 Week Low | $19.06 | $9.82 |
| 52 Week High | $29.25 | $21.45 |
Technical Indicators
Market Signals| Indicator | OSW | NVCR |
|---|---|---|
| Relative Strength Index (RSI) | 52.35 | 44.38 |
| Support Level | $23.14 | $13.33 |
| Resistance Level | $24.96 | $15.22 |
| Average True Range (ATR) | 0.55 | 0.65 |
| MACD | 0.08 | 0.11 |
| Stochastic Oscillator | 51.01 | 40.70 |
Price Performance
Historical ComparisonAbout OSW OneSpaWorld Holdings Limited
OneSpaWorld Holdings Ltd is an operator of health and wellness centers onboard cruise ships and an operator of health and wellness centers at destination resorts all over the world. It offers a suite of premium health, fitness, beauty, and wellness services and products. The services provided by the company include body, salon, and skin care services and products, fitness classes and personal fitness training and pain management, detoxifying programs, and comprehensive body composition analyses among others. The company has only one single segment of Maritime and Destination Resorts.
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.